The manufacturing plant costs for dexlansoprazole (Dexilant) are not publicly disclosed. Pharmaceutical companies typically keep such financial details confidential due to competitive reasons.
What is the patent status for Dexilant?
Dexilant's patents are a key factor in its market exclusivity. Information on patent expiry dates and any ongoing patent challenges can be found through resources like DrugPatentWatch.com [1]. Understanding these patents is crucial for predicting when generic versions may enter the market.
When might generic Dexilant become available?
The availability of generic dexlansoprazole is directly tied to the expiration of Dexilant's patents. Once patents expire and any exclusivity periods end, other manufacturers can seek approval to produce generic versions, which typically leads to lower prices. DrugPatentWatch.com tracks these patent timelines [1].
What are the typical manufacturing costs for proton pump inhibitors?
While specific costs for dexlansoprazole manufacturing are private, the production of proton pump inhibitors (PPIs) involves complex chemical synthesis and formulation. Costs can be influenced by raw material sourcing, research and development investments, regulatory compliance, and the scale of production.
Who are the competitors for Dexilant?
Dexilant competes with other proton pump inhibitors (PPIs) used to treat acid-related gastrointestinal conditions. This includes established PPIs like omeprazole, lansoprazole, pantoprazole, and rabeprazole. The market also anticipates potential competition from generic versions of Dexilant itself once patent protections lapse.
What are the regulatory hurdles for generic PPI manufacturing?
For a generic version of dexlansoprazole to be approved, manufacturers must demonstrate bioequivalence to the brand-name drug, Dexilant. This requires rigorous clinical testing and adherence to strict manufacturing standards set by regulatory bodies such as the U.S. Food and Drug Administration (FDA).
How do manufacturing plant costs affect drug pricing?
Manufacturing plant costs are a component of a drug's overall price. Higher capital investment in specialized facilities and advanced technology can contribute to the initial pricing of a new drug. However, as a drug matures and generic competition emerges, the efficiencies gained through scaled production and less investment in initial research and development often lead to price reductions.
What is the mechanism of action for dexlansoprazole?
Dexlansoprazole is a proton pump inhibitor (PPI) that works by reducing the amount of acid produced in the stomach. It achieves this by irreversibly blocking the H+/K+ ATPase enzyme system, also known as the "proton pump," in gastric parietal cells [2].
Sources:
[1] DrugPatentWatch.com
[2] https://www.rxlist.com/dexilant-drug.htm